Notice2024-07521
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 10, 2024
Issuing agencies
Defense Department
Abstract
The DoD is publishing this notice to announce that the following Federal advisory committee meeting of the Uniform Formulary Beneficiary Advisory Panel (UFBAP) was held on Wednesday, April 3, 2024.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 70 (Wednesday, April 10, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 70 (Wednesday, April 10, 2024)]
[Notices]
[Pages 25251-25252]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-07521]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal
Advisory Committee Meeting
AGENCY: Under Secretary of Defense for Personnel and Readiness,
Department of Defense (DoD).
ACTION: Notice of Federal advisory committee meeting.
-----------------------------------------------------------------------
SUMMARY: The DoD is publishing this notice to announce that the
following Federal advisory committee meeting of the Uniform Formulary
Beneficiary Advisory Panel (UFBAP) was held on Wednesday, April 3,
2024.
DATES: Open to the public Wednesday, April 3, 2024, from 10:00 a.m. to
1:00 p.m. eastern standard time.
ADDRESSES: The meeting was held telephonically or via conference call.
The phone number for the remote access on April 3, 2024, was CONUS: 1-
888-831-4306; OCONUS: 1-210-234-8694; PARTICIPANT CODE: 9136304.
These numbers and the dial-in instructions were posted on the UFBAP
website at: <a href="https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP">https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP</a>.
FOR FURTHER INFORMATION CONTACT: Designated Federal Officer (DFO)
Colonel (COL) Paul B. Carby, USA, 703-681-2890 (voice), <a href="/cdn-cgi/l/email-protection#c3a7aba2edada0b1eda9eef5edaea1bbeda1a2b3b1a6b2b6a6b0b7b083aba6a2afb7abedaeaaaf"><span class="__cf_email__" data-cfemail="ed89858cc3838e9fc387c0dbc3808f95c38f8c9d9f889c98889e999ead85888c819985c3808481">[email protected]</span></a> (email). Mailing address is 7700 Arlington
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: <a href="https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP">https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP</a>. The most up-to-date changes to the meeting
agenda can be found on the website.
SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of
the DFO, the UFBAP was unable to provide public notification required
by 41 CFR 102-3.150(a) concerning its April 3, 2024 meeting.
Accordingly, the Advisory Committee Management Officer for the DoD,
pursuant to 41 CFR 102-3.150(b), waives the 15-calendar day
notification requirement.
[[Page 25252]]
This meeting was held under the provisions of chapter 10 of title 5
United States Code (U.S.C.) (commonly known as the ``Federal Advisory
Committee Act'' or ``FACA''), 5 U.S.C. 552b (commonly known as the
``Government in the Sunshine Act'') and 41 CFR 102-3.140 and 102-3.150.
Purpose of the Meeting: The UFBAP reviewed and commented on
recommendations made by the Pharmacy and Therapeutics Committee to the
Director, Defense Health Agency regarding the Uniform Formulary.
Agenda:
1. 10:00 a.m.-10:10 a.m. Sign In for UFBAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
a. Welcome, Opening Remarks, and Introduction of UFBAP Members by
COL Paul B. Carby, DFO, UFBAP
b. Public Written Comments by COL Paul B. Carby, DFO, UFBAP
c. Opening Remarks by Mr. Jon Ostrowski, UFBAP Chair
d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary
Management Branch
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues
6. 12:45 p.m.-1:00 p.m. Closing remarks
a. Closing Remarks by UFBAP Co-Chair
b. Closing Remarks by DFO, UFBAP
Meeting Accessibility: Pursuant to 5 U.S.C. 1009(a)(1) and 41 CFR
102-3.140 through 102-3.165, and subject to the availability of phone
lines, this meeting was open to the public. Telephone lines were
limited and available to the first 220 people dialing in. There were
220 lines total: 200 domestic and 20 international, including leader
lines.
Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-
3.140(c), and 5 U.S.C. 1009(a)(3), interested persons or organizations
may submit written statements to the UFBAP about its mission and/or the
agenda to be addressed in this public meeting. Written statements
should be submitted to the UFBAP's DFO. The DFO's contact information
can be found in the FOR FURTHER INFORMATION CONTACT section of this
notice. Written comments or statements must be received by the UFBAP's
DFO so they may be made available to the UFBAP for its consideration.
Written comments received are releasable to the public. The DFO will
review all submitted written statements and provide copies to UFBAP.
Dated: April 3, 2024.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2024-07521 Filed 4-9-24; 8:45 am]
BILLING CODE 6001-FR-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 10, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.